These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9357429)

  • 1. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V
    Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronotherapy].
    Garufi C; Aschelter AM; Zappalà AR; Vanni B; Terzoli E
    Tumori; 2001; 87(6):A26-7. PubMed ID: 11995702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Future therapeutic prospectives for the treatment of advanced cancer of the colorectum: our experience with oxaliplatin combined with fluorofolates in chronoinfusions].
    Bumma C; Montrucchio G; Manzin E; Oletti MV
    Tumori; 2000; 86(3 Suppl):S26-8. PubMed ID: 10969613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronotherapy with 5-fluorouracil folinic acid and oxaliplatin delivered over 48 hours every second week in colorectal cancer. The CHC-Liège experience (Belgium)].
    Focan C; Demolin G; Kreutz F; Graas MP; Longrée L; Matus G; Moeneclaey N; Focan-Henrard D
    Pathol Biol (Paris); 2013 Oct; 61(5):e71-4. PubMed ID: 23089329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy.
    Lévi F; Zidani R; Misset JL
    Lancet; 1997 Sep; 350(9079):681-6. PubMed ID: 9291901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of Cancer.
    Garufi C; Dogliotti L; Terzoli E; Focan C; Smaaland R; Chollet P; Perpoint B; Lévi F
    Tumori; 1999; 85(2):149-50. PubMed ID: 10363085
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
    Chang DZ; Abbruzzese JL
    Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
    [No Abstract]   [Full Text] [Related]  

  • 8. Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients.
    Garufi C; Brienza S; Pugliese P; Aschelter AM; Bensmaine ; Bertheault-Cvitkovic F; Nisticò C; Giunta S; Caterino M; Giannarelli D; Cosimelli M; Lévi F; Terzoli E
    Anticancer Drugs; 2000 Jul; 11(6):495-501. PubMed ID: 11001391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.
    Sobrero AF
    J Clin Oncol; 2004 Jan; 22(1):4-6. PubMed ID: 14665617
    [No Abstract]   [Full Text] [Related]  

  • 10. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
    Hochster HS
    Clin Adv Hematol Oncol; 2005 May; 3(5):405-6. PubMed ID: 16167014
    [No Abstract]   [Full Text] [Related]  

  • 12. [The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
    Chauffert B; Bonnotte B; Chvetzoff G; Flesch M
    Presse Med; 1998 May; 27(18):859. PubMed ID: 9767871
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.
    Gholam D; Giacchetti S; Brézault-Bonnet C; Bouchahda M; Hauteville D; Adam R; Ducot B; Ghémard O; Kustlinger F; Jasmin C; Lévi F
    Oncologist; 2006; 11(10):1072-80. PubMed ID: 17110626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy in folinic acid administration after fluorouracil.
    Yildirim Y; Akcali Z; Ozyilkan O
    J Clin Oncol; 2005 Jun; 23(16):3862; author reply 3862-3. PubMed ID: 15923589
    [No Abstract]   [Full Text] [Related]  

  • 18. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer RJ
    J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796
    [No Abstract]   [Full Text] [Related]  

  • 19. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
    Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P
    Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer.
    Focan C
    Chronobiol Int; 2002 Jan; 19(1):289-97. PubMed ID: 11962682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.